Inactive Instrument

Press Releases Enzymatica AB Nasdaq Stockholm

Equities

SE0003943620

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024	05-07	AQ
BioStock: MDR certification was Enzymatica's highlight in Q1	04-29	AQ
Enzymatica Q1 - Continued growth in own markets, but a lack of partner orders	04-26	AQ
Interim report Q1/2024: MDR certification opens up great commercial opportunities	04-25	AQ
Enzymatica publishes annual report for 2023	04-09	AQ
Notice of Annual General Meeting 2024 in Enzymatica AB (publ)	03-27	AQ
BioStock: Enzymatica comments on MDR certification for ColdZyme	03-20	AQ
Enzymatica announces outcome of new rights issue	03-14	AQ
ColdZyme® certified under the new EU medical device regulation (MDR)	03-11	AQ
BioStock: Enzymatica's partners await MDR certification and study results	02-26	AQ
Enzymatica publishes information memorandum about rights issue of shares	02-19	AQ
Enzymatica Q4 - Important year ahead and an expected rights issue	02-19	AQ
Enzymatica's rights issue is secured to 100 percent	02-16	AQ
Year-end report 2023: Scientific and regulatory progress generating international interest	02-16	AQ
Enzymatica's Board of Directors decides on a new rights issue of SEK 27.4 million	02-16	AQ
Enzymatica's Chairman to BioStock: "Our new research data makes 2024 an exciting year"	12-21	AQ
Enzymatica changes Certified Adviser to Carnegie Investment Bank AB (publ)	11-30	AQ
BioStock: Enzymatica focuses on strengthening the distributor level	11-08	AQ
Enzymatica Q3 - The STADA partnership creating concerns about the future	11-08	AQ
Interim report Q3/2023: Research results that reshape the competitive landscape	11-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Enzymatica AB Nasdaq Stockholm

Equities

SE0003943620

Press Releases

Filters